Cardiovascular Diseases Clinical Trial
Official title:
The Effect of Mindfulness-Based Stress Reduction on Sleep Quality, Stress Physiology & CVD Risk
The goal of this study is to better understand the potential value of reducing stress to ameliorate a cluster of biological and behavioral factors implicated in cardiovascular disease (CVD) risk. These factors include psychological distress, poor sleep quality, and exaggerated physiological responses to emotional stress. Results will be used to develop an innovative brief intervention to reduce risk for CVD by improving sleep quality, ameliorating psychological distress, and attenuating stress physiology.
Status | Completed |
Enrollment | 87 |
Est. completion date | October 2013 |
Est. primary completion date | March 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: 1. Willing to participate in an 8 week stress reduction training program 2. Between 18 and 65 years old 3. Generally in good health and not taking medication 4. Able to speak and read English 5. Willing to provide informed consent 6. Able to access the internet 7. Able to attend 4 study visits at Duke University Medical Center Exclusion Criteria: 1. Younger than 18 years old/Older than 65 2. Asthma 3. Allergies 4. Arthritis 5. Autoimmune disease (Lupus) 6. Cancer 7. Cardiovascular disease, heart attack, or atherosclerosis 8. Diabetes or High Blood Sugar (>124 mg/dl) 9. Hypertension or high blood pressure (140/90 mmHg) 10. High cholesterol (>240 mg/dl) 11. Obesity (Body Mass Index >30) 12. Irritable Bowel Syndrome (IBS) 13. Mitral Valve Prolapse, or Heart Murmurs 14. Irregular Menstrual Cycles (Peri-Menopause Excluded. Menopause may be included.) 15. Skin conditions, such as eczema or psoriasis (acne may be included) 16. Sleep Apnea 17. Depression, anxiety, substance use, or any other mental health diagnosis 18. Sleep aids like Tylenol PM or Ambien on a regular basis 19. Medication for allergies or asthma on a regular basis 20. Aspirin or baby Aspirin on a regular basis 21. Oral contraceptives or birth control (women only) 22. Hormone Replacement Therapy 23. Flu shot within past 3 weeks 24. Underweight (BMI < 18.5) 25. Current smoker 26. >1 alcoholic drink/day (women)/ >2 alcoholic drinks/day (men) 27. Hospitalized within the last 3 months 28. Treated for any infections within the last 3 months 29. Current meditation practice >1x/month 30. Previously taken a Mindfulness-Based Stress Reduction (MBSR) course 31. Participation in any other research studies in the past year that involved drugs or taking blood 32. Recently donated blood. (500 cc's in last 8 wks) |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
United States | Duke Integrative Medicine | Durham | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Duke University | National Center for Complementary and Integrative Health (NCCIH) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Sleep quality | Sleep quality will be assessed using 3 different methods: daily sleep diaries, questionnaires and actigraphy. | Baseline, post-intervention (2 months), follow-up (8 months) | No |
Primary | Stress physiology | Physiological responses to mild emotional stress (5-minute Anger Recall Task) will be assessed in the laboratory before and after participating in an 8-week Mindfulness-Based Stress Reduction (MBSR) program. During the stress testing sessions, we will take measures of heart rate, blood pressure, stress hormones, metabolism, inflammation, emotions, and mindful qualities. | Baseline, post-intervention (2 months), follow-up (8 months) | No |
Secondary | Mindfulness | Mindful qualities, including observing, describing, non-judging, non-reactivity, acting with awareness, mindfulness, self-kindness, and common humanity. | Baseline, post-intervention (2 months), follow-up (8 months) | No |
Secondary | Health-related quality of life | Global health rating; physical functioning; fatigue; satisfaction with social role; pain intensity and pain-related interference with daily activities. | Baseline, post-intervention (2 months), follow-up (8 months) | No |
Secondary | Negative Affect | Anxiety; anger; depressive symptoms. | Baseline, post-intervention (2 months), follow-up (8 months) | No |
Secondary | Cognitive functioning | Cognitive abilities and concerns, including attention, concentration, memory, organization, and clarity of thinking. | Baseline, post-intervention (2 months), follow-up (8 months) | No |
Secondary | Emotion regulation | Rumination; avoidance; suppression; reappraisal. | Baseline, post-intervention (2 months), follow-up (8 months) | No |
Secondary | Stress-related physical symptoms | Common physical symptoms associated with stress, including muscle tension, gastrointestinal complaints, headaches, etc. | Baseline, post-intervention (2 months), follow-up (8 months) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|